A Phase Ib Study of RC1416 Injection

Clinical trial NCT06911866 · COMPLETED

Trial details

NCT number: NCT06911866
Sponsor: Nanjing RegeneCore Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Asthma

Start date: 2024-10-25
Primary completion: 2025-09-25
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.